Eley Financial Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.47M Buy
5,841
+21
+0.4% +$4.52K 0.48% 45
2026
Q1
$1.27M Buy
5,820
+91
+2% +$20.2K 0.46% 47
2025
Q4
$1.31M Buy
5,729
+85
+2% +$19.4K 0.47% 48
2025
Q3
$1.31M Sell
5,644
-2
-0% -$407 0.47% 48
2025
Q2
$1.05M Buy
5,646
+132
+2% +$24.5K 0.4% 52
2025
Q1
$1.14M Buy
5,514
+42
+0.8% +$8.16K 0.46% 53
2024
Q4
$972K Buy
5,472
+95
+2% +$17.5K 0.38% 56
2024
Q3
$1.06M Buy
+5,377
New +$1M 0.43% 54

Other funds holding ABBV

Eley Financial Management's ABBV Position: Q2 2026 in Review

Eley Financial Management increased its AbbVie (ABBV) stake by 0.36% in Q2 2026, buying an estimated $4.52K and bringing the position to 5,841 shares worth $1.47M. The position accounts for 0.48% of the portfolio, ranked #45.

Eley Financial Management first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Eley Financial Management held 5,841 shares of AbbVie worth $1.47M as of Q2 2026.
  • Eley Financial Management bought 21 AbbVie shares in Q2 2026, an estimated $4.52K.
  • AbbVie made up 0.48% of Eley Financial Management's portfolio in Q2 2026, its #45 holding.
  • Eley Financial Management first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Eley Financial Management's 13F filing for Q2 2026, filed 11 Aug 2026.